Ad is loading...
LMCQX
Price
$37.27
Change
-$0.31 (-0.82%)
Updated
Nov 15 closing price
VMVAX
Price
$87.94
Change
-$0.20 (-0.23%)
Updated
Nov 15 closing price
Ad is loading...

LMCQX vs VMVAX

Header iconLMCQX vs VMVAX Comparison
Open Charts LMCQX vs VMVAXBanner chart's image
Lord Abbett Mid Cap Stock R2
Price$37.27
Change-$0.31 (-0.82%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$87.94
Change-$0.20 (-0.23%)
VolumeN/A
CapitalizationN/A
LMCQX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMCQX vs. VMVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMCQX is a Buy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. LMCQX (1.23B). VMVAX pays higher dividends than LMCQX: VMVAX (2.14) vs LMCQX (0.20). LMCQX was incepted earlier than VMVAX: LMCQX (17 years) vs VMVAX (13 years). LMCQX is a more actively managed with annual turnover of: 41.00 vs. VMVAX (22.00). LMCQX has a lower initial minimum investment than VMVAX: LMCQX (0) vs VMVAX (3000). LMCQX (28.40) and VMVAX (27.09) have marching annual gain over last year. VMVAX return over 5 years is better than : 47.45 vs. LMCQX (34.41).
LMCQXVMVAXLMCQX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years13 years-
Gain YTD18.24217.355105%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B30.9B4%
Annual Yield % from dividends0.202.149%
Returns for 1 year28.4027.09105%
Returns for 3 years3.2213.5424%
Returns for 5 years34.4147.4573%
Returns for 10 years52.3396.8454%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NYMT5.960.04
+0.68%
New York Mortgage Trust
ELMD28.81-0.08
-0.28%
Electromed
ARCC21.51-0.07
-0.32%
Ares Capital Corp
APGE47.25-3.76
-7.36%
Apogee Therapeutics
BCDA1.85-0.17
-8.19%
BioCardia Inc.